ERBB2 and neoplasm: The median (range) age was similar in both groups (61.0 [22.0-103.0] years for the ERBB2-low group vs 61.0 [22.0-96.0] years for the ERBB2-zero group) as well as menopausal status, tumor grade, and number of metastatic sites (Table).